Now 75% off the original sale price of $3,250.
This Kalorama Information report details the scientific and market trends of the $4-billion cancer therapeutics market. Learn about the impact of chemotherapeutics, biologic agents, cancer vaccines, genetic therapies, and other emerging technologies. Find out about strategies companies are using to extend the life span of brand-name cancer therapeutic products that are coming off patent. Leading players are profiled.

Related Reports:

The Worldwide Market for Cancer Diagnostics, 4th Edition
Apr 1, 2010 - KLI2504623 - $4,200.00

The World Market for Biosimilars and the Potential for US Follow-on Biologics
Aug 1, 2009 - KLI2402283 - $3,700.00

High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer)
Jun 1, 2009 - KLI2155317 - $3,500.00

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
May 1, 2009 - KLI2218043 - $3,995.00

Women's Health: Worldwide Prescription Drug Markets
Feb 1, 2009 - KLI2071673 - $2,995.00

Protein Therapeutics: Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments, Global Market
Dec 1, 2008 - KLI1646601 - $2,995.00

Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis, 3rd Edition
Nov 1, 2008 - KLI1646591 - $3,995.00

Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
Mar 1, 2008 - KLI1597988 - $3,995.00

The Worldwide Market for Cancer Diagnostics, 3rd Edition
Mar 1, 2008 - KLI1393082 - $3,995.00

Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market
May 1, 2007 - KLI1469934 - $995.00